Trademark Overview
On Monday, January 26, 2026, a trademark application was filed for MEDGENIE with the United States Patent and Trademark Office. The USPTO has given the MEDGENIE trademark a serial number of 79448551. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, April 23, 2026. This trademark is owned by MedGenie AG. The MEDGENIE trademark is filed in the Computer & Software Products & Electrical & Scientific Products, Advertising, Business and Retail Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Updating and management of medical data, particularly in connection with medicines, food supplements, prescriptions, dosages and patient records in computer databases; computerized management of medical records and files.
Computer hardware; computer software; software and software applications; computer hardware and software for downloading, storing and synchronizing data (text and image files) in databases; computer software and computer applications for measuring, recording, monitoring and evaluating data related to patients' physical health; computer software and computer applications for evaluating pharmacogenomic data using individual genomic profiles of humans or animals; computer software and computer applications for creating and managing electronic patient records; software applications in the field of personalized medicine; software applications for visual representation of medical analyses concerning the interactions between chemical substances, medical substances and pharmaceutical products in relation to the human and animal body.
Advice with respect to health; health care; medical and veterinary care, advice and therapy services; medical services intended for medical (physical) condition monitoring, maintaining and improvement; advice in the field of personalized medicine; medical services in the field of personalized medicine; medical and veterinary services for monitoring, evaluating and improving drug treatments and drug therapies; performing medical analyses and providing medical interpretation (diagnosis) of medical analyses concerning the interactions between chemical substances, medical substances and pharmaceutical products in relation to the human and animal body.
